Metsera Announces Pricing of Initial Public Offering

Q: How long will it take to read this news story?

The story "Metsera Announces Pricing of Initial Public Offering" has 482 words across 16 sentences, which will take approximately 3 - 5 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Metsera Announces Pricing of Initial Public Offering" was covered 17 hours ago by Benzinga, a news publisher based in United States.

Q: How trustworthy is 'Benzinga' news outlet?

Benzinga is a fully independent (privately-owned) news outlet established in 2010 that covers mostly investing and business news. The outlet is headquartered in United States and publishes an average of 1 news stories per day. It's most recent story was published 1 days ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #25657245</li><li>URL: https://chronographically.beamstart.com/news/metsera-announces-pricing-of-initial-1738292518272</li></ul>

Benzinga Logo Benzinga 17h ago

Metsera Announces Pricing of Initial Public Offering - Benzinga

Quick Summary:

NEW YORK, Jan.30, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc.(NASDAQ:MTSR) ("Metsera"), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides to treat obesity, overweight and related conditions, today announced the pricing of its initial public offering of 15,277,778 shares of its common stock at a price to the public of $18.00 per share.

The gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by Metsera, are expected to be approximately $275.0 million, excluding any exercise of the underwriters' option to purchase additional shares.

Metsera's common stock is expected to begin trading on the Nasdaq Global Select Market under the ...